Amundi
ARVN icon

Amundi’s Arvinas ARVN Stock Holding History

Amundi’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,269
Closed -$208K – 1600
2025
Q2 		$208K Buy
26,269
+23,571
+874% +$174K ﹤0.01% 1600
2025
Q1 		$18.6K Sell
2,698
-4,809
-64% -$75.4K ﹤0.01% 1859
2024
Q4 		$149K Buy
7,507
+30
+0.4% +$729 ﹤0.01% 1754
2024
Q3 		$193K Sell
7,477
-186,188
-96% -$4.86M ﹤0.01% 1665
2024
Q2 		$4.63M Buy
193,665
+324
+0.2% +$10.3K ﹤0.01% 980
2024
Q1 		$6.63M Sell
193,341
-2,379
-1% -$104K ﹤0.01% 913
2023
Q4 		$7.7M Buy
195,720
+4,423
+2% +$103K ﹤0.01% 900
2023
Q3 		$3.22M Buy
191,297
+7,378
+4% +$181K ﹤0.01% 1061
2023
Q2 		$4.63M Buy
183,919
+177,192
+2,634% +$4.56M ﹤0.01% 1002
2023
Q1 		$191K Buy
6,727
+3,121
+87% +$98.6K ﹤0.01% 1578
2022
Q4 		$109K Buy
3,606
+2,344
+186% +$98.6K ﹤0.01% 1590
2022
Q3 		$57K Hold
1,262
– – ﹤0.01% 1646
2022
Q2 		$62K Buy
+1,262
New +$63.3K ﹤0.01% 1519
2021
Q4 		– Sell
-371
Closed -$30K – 1678
2021
Q3 		$30K Buy
+371
New +$32.8K ﹤0.01% 1545

Other funds holding ARVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Amundi's ARVN Position: Q3 2025 in Review

Amundi sold out of Arvinas (ARVN) in Q3 2025, closing a stake of 26,269 shares — an estimated $208K sold.

Amundi first reported a position in ARVN in Q3 2021 and held it in 14 quarters. The position peaked at $7.7M in Q4 2023. 211 funds tracked by Wall St. Rank hold ARVN as of Q3 2025.

  • Amundi reported no remaining Arvinas position as of Q3 2025 after selling out during the quarter.
  • Amundi sold 26,269 Arvinas shares in Q3 2025, an estimated $208K.
  • Amundi first reported a position in Arvinas in Q3 2021 and held it in 14 quarters.
  • Amundi's Arvinas position peaked at $7.7M in Q4 2023.
  • 211 funds tracked by Wall St. Rank held Arvinas as of Q3 2025.

Based on Amundi's 13F filing for Q3 2025, filed 14 Nov 2025.